177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model ; volume:6 ; number:1 ; day:13 ; month:6 ; year:2016 ; pages:1-9 ; date:12.2016
EJNMMI Research ; 6, Heft 1 (13.6.2016), 1-9, 12.2016
- Creator
-
Beykan, Seval
- Contributor
-
Dam, Jan S.
Eberlein, Uta
Kaufmann, Jens
Kjærgaard, Benedict
Jødal, Lars
Bouterfa, Hakim
Bejot, Romain
Laßmann, Michael
Jensen, Svend Borup
SpringerLink (Online service)
- DOI
-
10.1186/s13550-016-0204-9
- URN
-
urn:nbn:de:1111-201606158933
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beykan, Seval
- Dam, Jan S.
- Eberlein, Uta
- Kaufmann, Jens
- Kjærgaard, Benedict
- Jødal, Lars
- Bouterfa, Hakim
- Bejot, Romain
- Laßmann, Michael
- Jensen, Svend Borup
- SpringerLink (Online service)
Other Objects (12)
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
Radiomarkierung, Derivatisierung und Biodistribution eines Somatostatin-NOC-Analogons
Radiomarkierung, Derivatisierung und Biodistribution eines Somatostatin- NOC-Analogons
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC
Impact of different models based on blood samples and images for bone marrow dosimetry after 177Lu-labeled somatostatin-receptor therapy
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases
Human biodistribution and radiation dosimetry of the demyelination tracer [18F]3F4AP
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
Radiomarkierung, Derivatisierung und Biodistribution eines Somatostatin-NOC-Analogons
Radiomarkierung, Derivatisierung und Biodistribution eines Somatostatin- NOC-Analogons
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC
Impact of different models based on blood samples and images for bone marrow dosimetry after 177Lu-labeled somatostatin-receptor therapy
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases
Human biodistribution and radiation dosimetry of the demyelination tracer [18F]3F4AP
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment
Biodistribution and dosimetry of 177Lu-DOTA-IBA for therapy of bone metastases
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands
Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
Radiomarkierung, Derivatisierung und Biodistribution eines Somatostatin-NOC-Analogons
Radiomarkierung, Derivatisierung und Biodistribution eines Somatostatin- NOC-Analogons
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC
Impact of different models based on blood samples and images for bone marrow dosimetry after 177Lu-labeled somatostatin-receptor therapy
Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Comparison of the dosimetry and cell survival effect of 177Lu and 161Tb somatostatin analog radiopharmaceuticals in cancer cell clusters and micrometastases
Human biodistribution and radiation dosimetry of the demyelination tracer [18F]3F4AP